
    
      This post marketing clinical follow-up, randomised, double-blind study comparing the efficacy
      and tolerability of topical FLEXISEQÂ® with placebo for the treatment of osteoarthritis of the
      knee in patients contraindicated for or with clinical intolerance to NSAIDs and with OA of
      the knee will have a total individual treatment period of 12 weeks.
    
  